English

HEMPACCO CO., INC.

EDGAR

HPCO Annual report (10-K) · filed 2024-08-09

11 filing records in this dataset, filed from 2022-03-24 to 2024-08-09. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

This issuer has insider filings in the store, but no transaction in this window or code group.

See all insider transactions

Latest quarter

Revenue

2.04 million USD

2023 Q4 · USD

Exact inputs and evidence

Revenue: 4045637 USD Source
Revenue: 2004975 USD Source

Operating margin

-348.9%

2023 Q4 · %

Exact inputs and evidence

Operating Income: -13242237 USD Source
Operating Income: -6122401 USD Source
Revenue: 4045637 USD Source
Revenue: 2004975 USD Source

Operating cash flow

-873 thousand USD

2023 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -5844807 USD Source
Operating Cash Flow: -4972225 USD Source

Free cash flow

-889 thousand USD

2023 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -5844807 USD Source
Operating Cash Flow: -4972225 USD Source
Capital Expenditure: 179390 USD Source
Capital Expenditure: 163184 USD Source

Cash and cash equivalents: 110 thousand USD 2023-12-31 Source
Exact value

109825 USD
Long-term debt including current maturities: 0 USD 2023-12-31
Exact inputs and evidence

0 USD

Long-term debt including current maturities: 0 USD Source
Shares outstanding: 2.93 million shares 2023-12-31 Source
Exact value

2926905 shares

Reported share-count change

24.89% · 583 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

2343651 shares · 2022-12-31· Source
2926905 shares · 2023-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

4.05 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Revenue: 424360 USD · 2023-01-01 – 2023-03-31 Source
Revenue: 254601 USD · 2023-04-01 – 2023-06-30 Source
Revenue: 1326012 USD · 2023-07-01 – 2023-09-30 Source
Revenue: 4045637 USD · 2023-01-01 – 2023-12-31 Source
Revenue: 2004975 USD · 2023-01-01 – 2023-09-30 Source

Net income

-21.4 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Net income: -2378582 USD · 2023-01-01 – 2023-03-31 Source
Net income: -1611320 USD · 2023-04-01 – 2023-06-30 Source
Net income: 2261508 USD · 2023-07-01 – 2023-09-30 Source
Net income: -13442221 USD · 2023-01-01 – 2023-12-31 Source
Net income: 6251412 USD · 2023-01-01 – 2023-09-30 Source

Operating cash flow

-5.84 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Operating cash flow: -1956496 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -3821709 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -1956496 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -4972225 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -3821709 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -5844807 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: -4972225 USD · 2023-01-01 – 2023-09-30 Source

Capital expenditure

179 thousand USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Capital expenditure: 36187 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 148186 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 36187 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 163184 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 148186 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 179390 USD · 2023-01-01 – 2023-12-31 Source
Capital expenditure: 163184 USD · 2023-01-01 – 2023-09-30 Source

Free cash flow

-6.02 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Operating cash flow: -1956496 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -3821709 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -1956496 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -4972225 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -3821709 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -5844807 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: -4972225 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 36187 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 148186 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 36187 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 163184 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 148186 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 179390 USD · 2023-01-01 – 2023-12-31 Source
Capital expenditure: 163184 USD · 2023-01-01 – 2023-09-30 Source

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2024-08-09.

Financial data available through: 2023-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2023-12-31
Operating income: 4 of 11 periods available· newest 2023-12-31
Net income: 4 of 11 periods available· newest 2023-12-31
Operating cash flow: 4 of 11 periods available· newest 2023-12-31
Capital expenditure: 4 of 11 periods available· newest 2023-12-31
Total assets: 4 of 11 periods available· newest 2023-12-31
Total liabilities: 4 of 11 periods available· newest 2023-12-31
Current assets: 4 of 11 periods available· newest 2023-12-31
Current liabilities: 4 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2023-12-31
Long-term debt including current maturities: 4 of 11 periods available· newest 2023-12-31
Shares outstanding: 4 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+2%

Prior period

USD 3.97 million

2022-01-01 – 2022-12-31
Current period

USD 4.05 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

4045637 − 3967340 = 78297 USD

3967340 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
4045637 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · HEMPACCO CO., INC. · 2023-12-31 HEMPACCO CO., INC. (edgar:1892480) Year-over-year change in Revenue: 78297 USD Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480?view=overview&cadence=annual&surface=latest&basis=corrected#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 4045637 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#571796 Filing: 000147793224004612 Input fundies:Revenue: 3967340 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#572486 Filing: 000147793224004612
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 6.31 million

Prior period

−USD 7.13 million

2022-01-01 – 2022-12-31
Current period

−USD 13.44 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-13442221 − -7134957 = -6307264 USD

-7134957 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-13442221 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · HEMPACCO CO., INC. · 2023-12-31 HEMPACCO CO., INC. (edgar:1892480) Year-over-year change in Net income: -6307264 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480?view=overview&cadence=annual&surface=latest&basis=corrected#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -13442221 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#868238 Filing: 000147793224004612 Input fundies:NetIncome: -7134957 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#745056 Filing: 000147793224004612
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 1.47 million

Prior period

−USD 4.37 million

2022-01-01 – 2022-12-31
Current period

−USD 5.84 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-5844807 − -4370476 = -1474331 USD

-4370476 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-5844807 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · HEMPACCO CO., INC. · 2023-12-31 HEMPACCO CO., INC. (edgar:1892480) Year-over-year change in Operating cash flow: -1474331 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480?view=overview&cadence=annual&surface=latest&basis=corrected#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -5844807 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#868820 Filing: 000147793224004612 Input fundies:OperatingCashFlow: -4370476 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#787194 Filing: 000147793224004612
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+72.7%

Prior period

USD 103,868

2022-01-01 – 2022-12-31
Current period

USD 179,390

2023-01-01 – 2023-12-31

Exact inputs and evidence

179390 − 103868 = 75522 USD

103868 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
179390 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · HEMPACCO CO., INC. · 2023-12-31 HEMPACCO CO., INC. (edgar:1892480) Year-over-year change in Capital expenditure: 75522 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480?view=overview&cadence=annual&surface=latest&basis=corrected#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 179390 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#789229 Filing: 000147793224004612 Input fundies:CapitalExpenditure: 103868 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#789831 Filing: 000147793224004612
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 4.05 million 100% of revenue
Cost of revenue USD 5.05 million 125% of revenue
Operating expenses USD 12.03 million 297% of revenue
Other operating costs Derived USD 210,900 5.2% of revenue
Operating income −USD 13.24 million −327% of revenue
Tax, interest and other Derived USD 199,984 4.9% of revenue
Net income −USD 13.44 million −332% of revenue

Cash

Operating cash flow −USD 5.84 million −144% of revenue
Capital expenditure USD 179,390 4.4% of revenue
Free cash flow Derived −USD 6.02 million −149% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Operating loss: operating costs were 477% of revenue.
2021 Operating loss: operating costs were 240% of revenue.
2022 Operating loss: operating costs were 279% of revenue.
2023 Operating loss: operating costs were 427% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	345989	1650978 Derived	-1304989	160455 Derived	-1465444	-121117 Derived	Source 2020-01-01 – 2020-12-31: 345989 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -1304989 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -1465444 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -69686 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 51431 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	1187273	2846606 Derived	-1659333	211342 Derived	-1870675	-810924 Derived	Source 2021-01-01 – 2021-12-31: 1187273 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -1659333 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -1870675 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -730961 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 79963 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	3967340	11051562 Derived	-7084222	50735 Derived	-7134957	-4474344 Derived	Source 2022-01-01 – 2022-12-31: 3967340 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -7084222 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -7134957 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -4370476 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 103868 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	4045637	17287874 Derived	-13242237	199984 Derived	-13442221	-6024197 Derived	Source 2023-01-01 – 2023-12-31: 4045637 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -13242237 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -13442221 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -5844807 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 179390 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 4M 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Revenue	345989	Revenue: 345989 Open source
20212021-12-31	Revenue	1187273	Revenue: 1187273 Open source
20222022-12-31	Revenue	3967340	Revenue: 3967340 Open source
20232023-12-31	Revenue	4045637	Revenue: 4045637 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

2% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 345989 Open source
20212021-12-31	Year over year	243.2%	Revenue: 1187273 Open source Revenue: 345989 Open source
20222022-12-31	Year over year	234.2%	Revenue: 3967340 Open source Revenue: 1187273 Open source
20232023-12-31	Year over year	2%	Revenue: 4045637 Open source Revenue: 3967340 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -327.3% 2023

Net margin -332.3% 2023

Free cash flow margin -148.9% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	-377.2%	Operating Income: -1304989 Open source Revenue: 345989 Open source
20212021-12-31	Operating margin	-139.8%	Operating Income: -1659333 Open source Revenue: 1187273 Open source
20222022-12-31	Operating margin	-178.6%	Operating Income: -7084222 Open source Revenue: 3967340 Open source
20232023-12-31	Operating margin	-327.3%	Operating Income: -13242237 Open source Revenue: 4045637 Open source
20202020-12-31	Net margin	-423.6%	Net Income: -1465444 Open source Revenue: 345989 Open source
20212021-12-31	Net margin	-157.6%	Net Income: -1870675 Open source Revenue: 1187273 Open source
20222022-12-31	Net margin	-179.8%	Net Income: -7134957 Open source Revenue: 3967340 Open source
20232023-12-31	Net margin	-332.3%	Net Income: -13442221 Open source Revenue: 4045637 Open source
20202020-12-31	Free cash flow margin	-35%	Revenue: 345989 Open source Operating Cash Flow: -69686 Open source Capital Expenditure: 51431 Open source
20212021-12-31	Free cash flow margin	-68.3%	Revenue: 1187273 Open source Operating Cash Flow: -730961 Open source Capital Expenditure: 79963 Open source
20222022-12-31	Free cash flow margin	-112.8%	Revenue: 3967340 Open source Operating Cash Flow: -4370476 Open source Capital Expenditure: 103868 Open source
20232023-12-31	Free cash flow margin	-148.9%	Revenue: 4045637 Open source Operating Cash Flow: -5844807 Open source Capital Expenditure: 179390 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -5.8M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Operating cash flow	-69686	Operating Cash Flow: -69686 Open source
20212021-12-31	Operating cash flow	-730961	Operating Cash Flow: -730961 Open source
20222022-12-31	Operating cash flow	-4370476	Operating Cash Flow: -4370476 Open source
20232023-12-31	Operating cash flow	-5844807	Operating Cash Flow: -5844807 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -6M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Free cash flow	-121117	Operating Cash Flow: -69686 Open source Capital Expenditure: 51431 Open source
20212021-12-31	Free cash flow	-810924	Operating Cash Flow: -730961 Open source Capital Expenditure: 79963 Open source
20222022-12-31	Free cash flow	-4474344	Operating Cash Flow: -4370476 Open source Capital Expenditure: 103868 Open source
20232023-12-31	Free cash flow	-6024197	Operating Cash Flow: -5844807 Open source Capital Expenditure: 179390 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

104.3% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Liabilities / assets	60.7%	Total Liabilities: 3435326 Open source Total Assets: 5657894 Open source
20212021-12-31	Liabilities / assets	62.1%	Total Liabilities: 4702863 Open source Total Assets: 7570523 Open source
20222022-12-31	Liabilities / assets	20.3%	Total Liabilities: 1921980 Open source Total Assets: 9482179 Open source
20232023-12-31	Liabilities / assets	104.3%	Total Liabilities: 18822405 Open source Total Assets: 18043080 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.25× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	0.03×	Current Assets: 101462 Open source Current Liabilities: 2931761 Open source
20212021-12-31	Current assets / current liabilities	0.51×	Current Assets: 2117638 Open source Current Liabilities: 4168264 Open source
20222022-12-31	Current assets / current liabilities	1.25×	Current Assets: 1907807 Open source Current Liabilities: 1520434 Open source
20232023-12-31	Current assets / current liabilities	0.25×	Current Assets: 3279296 Open source Current Liabilities: 12891404 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−USD 1.47 million Exact value Exact value: -1465444 USD 2020-01-01 – 2020-12-31: -1465444 USD Inspect Net Income Open source Share or cite Citation for Net Income · HEMPACCO CO., INC. · 2020-12-31 HEMPACCO CO., INC. (edgar:1892480) Net Income: -1465444 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&basis=corrected&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1465444 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793223000749/hemp_s1.htm#1163271 Filing: 000147793223000749 The citation records this snapshot. The page link may show a newer release later.	−USD 69,686 Exact value Exact value: -69686 USD 2020-01-01 – 2020-12-31: -69686 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HEMPACCO CO., INC. · 2020-12-31 HEMPACCO CO., INC. (edgar:1892480) Operating Cash Flow: -69686 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&basis=corrected&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -69686 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793223000749/hemp_s1.htm#1319487 Filing: 000147793223000749 The citation records this snapshot. The page link may show a newer release later.	USD 51,431 Exact value Exact value: 51431 USD 2020-01-01 – 2020-12-31: 51431 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HEMPACCO CO., INC. · 2020-12-31 HEMPACCO CO., INC. (edgar:1892480) Capital Expenditure: 51431 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&basis=corrected&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 51431 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793223000749/hemp_s1.htm#1323361 Filing: 000147793223000749 The citation records this snapshot. The page link may show a newer release later.	−USD 121,117 Calculation and evidence -69686 − 51431 USD Exact free cash flow: -121117 USD 2020-01-01 – 2020-12-31: -69686 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 51431 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HEMPACCO CO., INC. · 2020-12-31 HEMPACCO CO., INC. (edgar:1892480) Free cash flow: -121117 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480?view=overview&cadence=annual&surface=latest&basis=corrected#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -69686 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793223000749/hemp_s1.htm#1319487 Filing: 000147793223000749 Input fundies:CapitalExpenditure: 51431 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793223000749/hemp_s1.htm#1323361 Filing: 000147793223000749 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 1.87 million Exact value Exact value: -1870675 USD 2021-01-01 – 2021-12-31: -1870675 USD Inspect Net Income Open source Share or cite Citation for Net Income · HEMPACCO CO., INC. · 2021-12-31 HEMPACCO CO., INC. (edgar:1892480) Net Income: -1870675 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&basis=corrected&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1870675 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224000437/hemp_s1.htm#1170419 Filing: 000147793224000437 The citation records this snapshot. The page link may show a newer release later.	−USD 730,961 Exact value Exact value: -730961 USD 2021-01-01 – 2021-12-31: -730961 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HEMPACCO CO., INC. · 2021-12-31 HEMPACCO CO., INC. (edgar:1892480) Operating Cash Flow: -730961 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&basis=corrected&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -730961 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224000437/hemp_s1.htm#1273848 Filing: 000147793224000437 The citation records this snapshot. The page link may show a newer release later.	USD 79,963 Exact value Exact value: 79963 USD 2021-01-01 – 2021-12-31: 79963 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HEMPACCO CO., INC. · 2021-12-31 HEMPACCO CO., INC. (edgar:1892480) Capital Expenditure: 79963 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&basis=corrected&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 79963 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224000437/hemp_s1.htm#1276487 Filing: 000147793224000437 The citation records this snapshot. The page link may show a newer release later.	−USD 810,924 Calculation and evidence -730961 − 79963 USD Exact free cash flow: -810924 USD 2021-01-01 – 2021-12-31: -730961 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 79963 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HEMPACCO CO., INC. · 2021-12-31 HEMPACCO CO., INC. (edgar:1892480) Free cash flow: -810924 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480?view=overview&cadence=annual&surface=latest&basis=corrected#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -730961 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224000437/hemp_s1.htm#1273848 Filing: 000147793224000437 Input fundies:CapitalExpenditure: 79963 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224000437/hemp_s1.htm#1276487 Filing: 000147793224000437 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 7.13 million Exact value Exact value: -7134957 USD 2022-01-01 – 2022-12-31: -7134957 USD Inspect Net Income Open source Share or cite Citation for Net Income · HEMPACCO CO., INC. · 2022-12-31 HEMPACCO CO., INC. (edgar:1892480) Net Income: -7134957 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&basis=corrected&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7134957 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#745056 Filing: 000147793224004612 The citation records this snapshot. The page link may show a newer release later.	−USD 4.37 million Exact value Exact value: -4370476 USD 2022-01-01 – 2022-12-31: -4370476 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HEMPACCO CO., INC. · 2022-12-31 HEMPACCO CO., INC. (edgar:1892480) Operating Cash Flow: -4370476 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&basis=corrected&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4370476 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#787194 Filing: 000147793224004612 The citation records this snapshot. The page link may show a newer release later.	USD 103,868 Exact value Exact value: 103868 USD 2022-01-01 – 2022-12-31: 103868 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HEMPACCO CO., INC. · 2022-12-31 HEMPACCO CO., INC. (edgar:1892480) Capital Expenditure: 103868 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&basis=corrected&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 103868 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#789831 Filing: 000147793224004612 The citation records this snapshot. The page link may show a newer release later.	−USD 4.47 million Calculation and evidence -4370476 − 103868 USD Exact free cash flow: -4474344 USD 2022-01-01 – 2022-12-31: -4370476 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 103868 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HEMPACCO CO., INC. · 2022-12-31 HEMPACCO CO., INC. (edgar:1892480) Free cash flow: -4474344 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480?view=overview&cadence=annual&surface=latest&basis=corrected#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4370476 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#787194 Filing: 000147793224004612 Input fundies:CapitalExpenditure: 103868 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#789831 Filing: 000147793224004612 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 13.44 million Exact value Exact value: -13442221 USD 2023-01-01 – 2023-12-31: -13442221 USD Inspect Net Income Open source Share or cite Citation for Net Income · HEMPACCO CO., INC. · 2023-12-31 HEMPACCO CO., INC. (edgar:1892480) Net Income: -13442221 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&basis=corrected&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13442221 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#868238 Filing: 000147793224004612 The citation records this snapshot. The page link may show a newer release later.	−USD 5.84 million Exact value Exact value: -5844807 USD 2023-01-01 – 2023-12-31: -5844807 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HEMPACCO CO., INC. · 2023-12-31 HEMPACCO CO., INC. (edgar:1892480) Operating Cash Flow: -5844807 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&basis=corrected&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5844807 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#868820 Filing: 000147793224004612 The citation records this snapshot. The page link may show a newer release later.	USD 179,390 Exact value Exact value: 179390 USD 2023-01-01 – 2023-12-31: 179390 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HEMPACCO CO., INC. · 2023-12-31 HEMPACCO CO., INC. (edgar:1892480) Capital Expenditure: 179390 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&basis=corrected&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 179390 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#789229 Filing: 000147793224004612 The citation records this snapshot. The page link may show a newer release later.	−USD 6.02 million Calculation and evidence -5844807 − 179390 USD Exact free cash flow: -6024197 USD 2023-01-01 – 2023-12-31: -5844807 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 179390 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HEMPACCO CO., INC. · 2023-12-31 HEMPACCO CO., INC. (edgar:1892480) Free cash flow: -6024197 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Value basis: Corrected Published: 2026-11-15T19:02:16Z Snapshot: cd3e2abe099c90ca71cd098e7b7078a2e4ebd2c21c89044bbb004c463ce140a0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1892480?view=overview&cadence=annual&surface=latest&basis=corrected#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5844807 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#868820 Filing: 000147793224004612 Input fundies:CapitalExpenditure: 179390 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1892480/000147793224004612/hpco_10k.htm#789229 Filing: 000147793224004612 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

11 filings · 686 latest values · 686 originally reported values

Dataset published 2026-11-15. Source filing dates and reporting periods are shown separately.

Identifiers: 0001892480, 1892480, HPCO, edgar:1892480

Also known as HEMPACCO CO. INC., HEMPACCO CO., INC., Hempacco Co., Inc.

HEMPACCO CO., INC.

Holdings and insider activity

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation